Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphoma

Leukemia

Volumn 14, Issue 2, 2000, Pages 271-277

  Fassone, L ^a   Bhatia, K ^b   Gutierrez, M ^b   Capello, D ^a   Gloghini, A ^c   Dolcetti, R ^d   Vivenza, D ^a   Ascoli, V ^e   Lo Coco, F ^e   Pagani, L ^f   Dotti, G ^g   Rambaldi, A ^g   Raphael, M ^h   Tirelli, U ^d   Saglio, G ⁱ   Magrath, I T ^b   Carbone, A ^c   Gaidano, G ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Division of Pathology   (Italy)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f Department of Orthopaedic Surgery   (Italy)

^g OSPEDALI RIUNITI   (Italy)

^h UNIVERSITÉ PARIS 13   (France)

ⁱ UNIVERSITY OF TURIN   (Italy)

Author keywords

AIDS; EBV; HHV 8; Immunodeficiency; Primary effusion lymphoma; Transplantation

Indexed keywords

TRANSFORMING PROTEIN;

ARTICLE; CLONAL ANERGY; CODON; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE DELETION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNOCOMPETENCE; LYMPHOMA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; VIRUS GENE; VIRUS INFECTION;

EID: 0033951414     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401651     Document Type: Article

References (45)

1. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New Engl J Med 1995; 332: 1186-1191.
2. Gaidano G, Pastore C, Gloghini A, Cusini M, Nomdedeu J, Volpe G, Capello D, Vaccher E, Bordes R, Tirelli U, Saglio G, Carbone A. Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia. AIDS 1996; 10: 941-949.
3. Nador R, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Said J, Knowles DM. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996; 88: 645-656.
4. Karcher DS, Alkan S. Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: a unique B cell neoplasm. Hum Pathol 1997; 28: 801-808.
5. Jones D, Ballestas ME, Kaye KM, Gulizia JM, Winters GL, Fletcher J, Scadden DT, Aster JC. Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. New Engl J Med 1998; 339: 444-449.
6. Dotti G, Fiocchi R, Motta T, Facchinetti B, Chiodini B, Borleri GM, Gavazzeni G, Barbui T, Rambaldi A. Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8. Leukemia 1999; 13: 664-670.
7. Jaffe ES. Primary body cavity-based AIDS-related lymphomas. Evolution of a new disease entity. Am J Clin Pathol 1996; 105: 141-143.
8. Otsuki T, Kumar S, Ensoli B, Kingma DW, Yano T, Stetler-Stevenson M, Jaffe ES, Raffeld M. Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. Leukemia 1996; 10: 1358-1362.
9. Gessain A, Briere J, Angelin-Duclos C, Valensi F, Beral HM, Davi F, Nicola MA, Sudaka A, Fouchard N, Babarre J, Troussard X, Dulmet E, Audouin J, Diebold J, de Thé G. Human herpes virus 8 (Kaposi's sarcoma herpesvirus) and malignant lymphoproliferations in France: a molecular study of 250 cases including two AIDS-associated body cavity based lymphomas. Leukemia 1997; 11: 266-272.
10. Uphoff CC, Habig S, Carbone A, Gaidano G, Drexler HG. HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas. Leukemia 1998; 12: 1806-1809.
11. Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. Am J Clin Pathol 1999; 111 (Suppl. 1): S8-S12.
12. Horenstein MG, Nador RG, Chadburn A, Hyjek EM, Inghirami G, Knowles DM, Cesarman E. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Blood 1997; 90: 1186-1191.
13. Chang Y, Moore PS, Talbot SJ, Boshoff CH, Zarkowska T, Godden-Kent D, Paterson H, Weiss RA, Mittnacht S. Cyclin encoded by KS herpesvirus. Nature 1996; 382: 410.
14. Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996; 274: 1739-1744.
15. Ruf IK, Rhyne PW, Yang H, Borza CM, Hutt-Fletcher LM, Cleveland JL, Sample JT. Epstein-Barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma. Mol Cell Biol 1999; 19: 1651-1660.
16. Komano J, Sugiura M, Takada K. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. J Virol 1998; 72: 9150-9156.
17. Kube D, Vockerodt M, Weber O, Hell K, Wolf J, Haier B, Grasser FA, Muller-Lantzsch N, Kieff E, Diehl V, Tesch H. Expression of Epstein-Barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428. J Virol 1999; 73: 1630-1636.
18. Wilson JB, Bell JL, Levine AJ. Expression of Epstein-Barr virus antigen-1 induces B cell neoplasia in transgenic mice. EMBO J 1996; 15: 3117-3126.
19. Rowe M, Rowe D, Gregory C, Young L, Farrel P, Rupani H, Rickinson A. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt lymphoma cells. EMBO 1987; 6: 2743-2751.
20. Klein G. Viral latency and transformation: the strategy of Epstein-Barr virus. Cell 1989; 58: 5-8.
21. Rickinson AB, Kieff E. Epstein-Barr virus. In: Fields BN (ed). Virology. Lippincott-Raven: Philadelphia, 1996, pp 2397-2404.
22. Bhatia K, Raj A, Gutierrez MI, Judde J-G, Spangler G, Venkatesh H, Magrath IT. Variation in the sequence of Epstein-Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene 1996; 13: 177-181.
23. Gutierrez MI, Raj A, Spangler G, Sharma A, Hussain A, Judde J-G, Tsao SW, Yuen PW, Joab I, Magrath IT, Bhatia K. Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells. J Gen Virol 1997; 78: 1663-1670.
24. Gutierrez MI, Spangler G, Kingma D, Raffeld M, Guerrero I, Misad O, Jaffe ES, Magrath IT, Bhatia K. Epstein-Barr virus in nasal lymphomas contain multiple ongoing mutations in the EBNA-1 gene. Blood 1998; 92: 600-606.
25. Triantos D, Boulter AW, Leao JC, Di Alberti L, Porter SR, Scully CM, Birnbaum W, Johnson NW, Teo CG. Diversity of naturally occurring Epstein-Barr virus revealed by nucleotide sequence polymorphism in hypervariable domains in the BamHI K and N subgenomic regions. J Gen Virol 1998; 79: 2809-2817.
26. Chen Y-Y, Chang KL, Chen W-G, Shibata D, Hayashi K, Weiss LM. Epstein-Barr virus-associated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma. Lab Invest 1998; 78: 877-882.
27. Habeshaw G, Yao QY, Bell AI, Morton D, Rickinson AB. Epstein-Barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas. J Virol 1999; 73: 965-975.
28. Chang KL, Chen Y-Y, Chen W-G, Hayashi K, Bacchi C, Bacchi M, Weiss LM. EBNA-1 gene sequences in Brazilian and American patients with Hodgkin's disease. Blood 1999; 94: 244-250.
29. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995; 86: 2708-2714.
30. Drexler HG, Uphoff CC, Gaidano G, Carbone A. Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas). Leukemia 1998; 12: 1507-1517.
31. Drexler HG, Meyer C, Gaidano G, Carbone A. Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines. Leukemia 1999; 13: 634-640.
32. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C, Tuffnell PS, Barrell BG. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 1984; 310: 207-211.
33. Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996; 88: 242-251.
34. Klein C, Rothenberger S, Niemeyer C, Bachmann E, Odermatt B, Bohm N, Brandis M, Knecht H. EBV-associated lymphoproliferative syndrome with a distinct 69 base-pair deletion in the LMP-1 oncogene. Br J Haematol 1995; 91: 938-940.
35. Khanim F, Yao Q-YY, Niedobitek G, Sihota S, Rickinson AB, Young LS. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 1996; 88: 3491-3501.
36. Walling DM, Edmistan SN, Sixbey JW, Abdel-Hamid M, Resnick L, Raab-Traub N. Co-infection of multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplachia. Proc Natl Acad Sci USA 1992; 89: 6560-6564.
37. Yao QY, Tierney RJ, Croom-Carter D, Dukers D, Cooper GM, Ellis CJ, Rowe M, Rickinson AB. Frequency of multiple Epstein-Barr virus infections in T cell immunocompromised hosts. J Virol 1996; 70: 4884-4894.
38. Sample J, Kieff E, Kieff E. Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes. J Gen Virol 1994; 75: 2741-2746.
39. Miller WE, Hood Edwards R, Walling DM, Raab-Traub N. Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol 1994; 75: 2729-2740.
40. Boyle MJ, Sewell WA, Sculley TB, Apolloni A, Turner JJ, Swanson CE, Penny R, Cooper DA. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood 1991; 78: 3004-3011.
41. Goldschmidts WL, Bhatia K, Franklin Johnson J, Akar N, Gutierrez MI, Shibata D, Carolan M, Levine A, Magrath IT. Epstein-Barr virus genotypes in AIDS-associated lymphomas are similar to those in endemic Burkitt's lymphomas. Leukemia 1992; 6: 875-878.
42. Menin C, Ometto L, Veronesi A, Montagna M, Coppola V, Veronese ML, Indraccolo S, Bruni L, Corneo B, Amadori A, De Rossi A, Chieco-Bianchi L, D'Andrea E. Dominance of a single Epstein-Barr virus strain in SCID-mouse tumours induced by injection of peripheral blood mononuclear cells from healthy human donors. Virus Res 1995; 36: 215-231.
43. Schuster V, Ott G, Seidenspinner S, Kreth HW. Common Epstein-Barr virus (EBV) type-1 variant strains in both malignant and benign EBV-associated disorders. Blood 1996; 87: 1579-1585.
44. Ometto L, Menin C, Masiero S, Bonaldi L, Del Mistro A, Cattelan AM, D'Andrea E, De Rossi A, Chieco-Bianchi L. Molecular profile of Epstein-Barr virus in human immunodeficiency virus type 1-related lymphadenopathies and lymphomas. Blood 1997; 90: 313-322.
45. Dolcetti R, Quaia M, Gloghini A, De Re V, Zancai P, Cariati P, Babuin L, Cilia AM, Rizzo S, Carbone A, Boiocchi M. Biologically relevant phenotypic changes and enhanced growth properties induced in B lymphocytes by an EBV strain derived from a histologically aggressive Hodgkin's disease. Int J Cancer 1999; 80: 240-249.